Abstract: The present invention relates to a construction improvement of the piston valve in compressing pump with features as below: The discharge base, which is built in the center of the piston valve, is contrived into planar shape; Some discharge spouts are created on said discharge base in corresponding with each said inlet slots; An orientating lump is created in the top center of said discharge base and being punched an orientating hole at its center; The anti-backflow plastic gasket, which is contrived into 3-blade planar shape to entirely cover the top of said discharge base, has a gap cleft created between each blade so that each said blade can closely block exactly each said corresponding inlet slots on said discharge base respectively; During each said wobble wheels of the compressing pump pushing said diaphragm in turns, the water flow, which coming from each said inlet slot at each area, will continuously runs into each said discharge spout at each area in said discharge base by turns so that each blade o

Abstract: An electronic item management and archival system for managing and archiving items. Each item includes at least one of image data, audio data, and video data. The system includes a server configured to receive items, archive at least one of the received items to an archive, and retrieve at least one of the archived items from the archive. In some embodiments, the server also includes architecture that supports a pool of threads promoting multiple, independent archive and retrieve operations concurrently.

Abstract: The invention relates to compounds of the general formula wherein (R1)n is independently from from each other halogen, lower alkyl or lower alkoxy; R2 is hydrogen, lower alkyl, lower halogen-alkyl, —(CH2)m—OH, —(CH2)m—NR2, —(CH2)mO-lower alkyl, —(CH2)m—C(O)—NR2, or is —(CH2)m-6-membered heteroaryl, optionally substituted by one or more lower alkoxy, —(CH2)m-5 or 6-membered not aromatic heterocyclyl, optionally substituted by hydroxy or lower alkyl; R is hydrogen or lower alkyl and may be the same or different in case of R2; n is 0, 1, or 2; m is 0, 1, 2, 3 or 4; and pharmaceutically acceptable acid addition salts thereof. These compounds have a good affinity to the NK-1 receptor and they are therefore suitable for the treatment of diseases, related to this receptor.

Abstract: The invention relates to compounds of the general formula 1